Ibuprofen
| Material: | 1 ml serum |
| Methods: | Hochleistungsflüssigkeitschromatographie (HPLC) → Hochleistungsflüssigkeitschromatographie (HPLC) |
| Indication | Therapeutic drug monitoring |
| Therapeutic range | 15 mg/l – 30 mg/l Toxic: > 100 mg/l |
| Please note | Ibuprofen is a non-steroidal antirheumatic (NSAR) and has an analgesic, antipyretic, antiphlogistic and slight thrombocyte aggregation inhibiting effect. Known side effects are heartburn, in case of long-term treatment development of ventricular ulcers, dosage dependent increase of tendency to bleeding, transaminase increase, interstitial nephritis and oversensitivity reactions possible. |
| Accredited | ja |
More Results for the letter I
- IA2-autoantibodies (IA2)
- Antibodies against islet cell specific tyrosine phosphatase
- Ibuprofen (IBU)
- IgE, total (IgE)
- IGF-1 (SOMA)
- Insulin like growth factor 1, somatomedin C
- IGFBP-3 (IGFBP3)
- Insulin like growth factor binding protein 3
- Imipramine (IMI)
- Immune complexes, circulating (ZIIK)
- ZIK, CIC
- Immunofixation in serum (IE)
- Immunofixation in the urine (FIXU)
- Immunoglobulins (IGGL)
- IgG in CSF
- Immunoglobulins, IgA in CSF (IGAL)
- Immunoglobulins, IgA in serum (IGA)
- Immunoglobulins, IgA in urine (IGAU)
- Immunoglobulins, IgD in serum (IGD)
- Immunoglobulins, IgE in serum (IGE)
- Immunoglobulins, IgG in serum (IGG)
- Immunoglobulins, IgG in urine (IGGU)
- Immunoglobulins, IgG-subclasses in serum (IGGSK)
- Immunoglobulins, IgM in CSF (IGML)
- Immunoglobulins, IgM in serum (IGM)
- Immunoglobulins, IgM in urine (IGMU)
- Infectious mononucleosis (EBV)
- Pfeiffer’s disease
- Influenza virus infection (INFL)
- Influenza viruses A, B, incl. H5N1 family of orthomyxoviruses
- Inhibiting substances, detection in urine, cerebrospinal fluid and sputum (INHI)
- Inhibitor detection in CSF, urine and sputum (HEMM)
- INR value (QUICK)
- International normalized ratio, Quick’s value, Quick’s test
- Insulin (INSU)
- Insulin-autoantibodies (INSUL)
- IAA
- Interleukin-1-risk allele (PRTPCR)
- Interleukin-2-receptor, soluble (INLEU2)
- sIL-2R